Heparanase Inhibitor as Anti-Metastatic Therapy for Myeloma.

Grant

Date/time Interval

  • September 1, 2009 - February 28, 2011
  • Total Award Amount

  • 75000.00
  • Direct Costs

  • 68182.00
  • Sponsor Award Id

  • Contributor

  • Sanderson Ph.D., Ralph   Principal Investigator